Compugen

Compugen Debt-to-Equity

Debt-to-Equity Ratio of Compugen (CGEN) as of Oct 19, 2026.

Debt-to-Equity

0.00

Last updated:

Debt-to-Equity Ratio of Compugen is 2025 0.00 . Debt-to-Equity Ratio of Compugen was 2024 0.00 . It decreases by % lower compared to the previous year.

The Compugen Debt-to-Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt-to-Equity
Date
Debt-to-Equity
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The Compugen Debt-to-Equity history
YEARDebt-to-EquityYoY
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

On Eulerpool you can find the complete historical development of Debt-to-Equity Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Equity ratio measures financial leverage by comparing total debt to shareholders' equity. Higher ratios indicate more debt financing relative to equity.

Debt/Equity = Total Debt / Shareholders' Equity

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Equity Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Compugen

All Key Metrics — Compugen